Evidence map›Paper›PMID 37569458›Full record

ArticleInternational journal of molecular sciences2023

Evaluation of Immune Infiltrates in Ovarian Endometriosis and Endometriosis-Associated Ovarian Cancer: Relationship with Histological and Clinical Features.

Emanuela Spagnolo, Alejandra Martinez, Andrea Mascarós-Martínez, Josep Marí-Alexandre, María Carbonell, Eva González-Cantó, Eva Manuela Pena-Burgos, Bárbara Andrea Mc Cormack, Sarai Tomás-Pérez, Juan Gilabert-Estellés and 6 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Emanuela SpagnoloDepartment of Gynecology, La Paz University Hospital, 28046 Madrid, Spain.ORCID 0000-0001-5566-8479
Alejandra MartinezDepartment of Surgical Oncology, Institut Claudius Regaud-Institut Universitaire du Cancer du Toulouse (IUCT) Oncopole, 31059 Toulouse, France.
Andrea Mascarós-MartínezDepartment of Pathology, General University Hospital of Valencia, 46014 Valencia, Spain.
Josep Marí-AlexandreDepartment of Pathology, General University Hospital of Valencia, 46014 Valencia, Spain.ORCID 0000-0003-0625-4901
María CarbonellDepartment of Gynecology, La Paz University Hospital, 28046 Madrid, Spain.ORCID 0000-0001-9287-0182
Eva González-CantóResearch Laboratory in Biomarkers in Reproduction, Obstetrics and Gynecology, Research Foundation, General University Hospital of Valencia, 46014 Valencia, Spain.
Eva Manuela Pena-BurgosDepartment of Pathology, La Paz University Hospital, 28046 Madrid, Spain.
Bárbara Andrea Mc CormackResearch Laboratory in Biomarkers in Reproduction, Obstetrics and Gynecology, Research Foundation, General University Hospital of Valencia, 46014 Valencia, Spain.ORCID 0000-0002-9246-5766
Sarai Tomás-PérezResearch Laboratory in Biomarkers in Reproduction, Obstetrics and Gynecology, Research Foundation, General University Hospital of Valencia, 46014 Valencia, Spain.
Juan Gilabert-EstellésResearch Laboratory in Biomarkers in Reproduction, Obstetrics and Gynecology, Research Foundation, General University Hospital of Valencia, 46014 Valencia, Spain.
Ana López-CarrascoDepartment of Gynecology, La Paz University Hospital, 28046 Madrid, Spain.
Paula HidalgoDepartment of Radiology, La Paz University Hospital, 28046 Madrid, Spain.
Martina Aida ÁngelesDepartment of Surgical Oncology, Institut Claudius Regaud-Institut Universitaire du Cancer du Toulouse (IUCT) Oncopole, 31059 Toulouse, France.ORCID 0000-0003-4401-3084
Andrés RedondoDepartment of Medical Oncology, La Paz University Hospital, 28046 Madrid, Spain.
Alejandro GallegoDepartment of Medical Oncology, La Paz University Hospital, 28046 Madrid, Spain.
Alicia HernándezDepartment of Gynecology, La Paz University Hospital, 28046 Madrid, Spain.
Hospital Universitario La Paz · ESHospital General Universitario De Valencia · ESInserm · FRInstitut Claudius Regaud · FRUniversitat de València · ES

Funding

Instituto Carlos III PI20/01368
6 · The paper itself

Abstract

backgroundthe association between ovarian endometriosis (OE) and endometriosis-associated ovarian cancer (EAOC) is extensively documented, and misfunction of the immune system might be involved. The primary objective of this study was to identify and compare the spatial distribution of tumour-infiltrating lymphocytes (TILs) and tumour-associated macrophages (TAMs) in OE and EAOC. Secondary objectives included the analysis of the relationship between immunosuppressive populations and T-cell exhaustion markers in both groups.

methodsTILs (CD3, CD4, and CD8) and macrophages (CD163) were assessed by immunochemistry. Exhaustion markers (PD-1, TIM3, CD39, and FOXP3) and their relationship with tumour-associated macrophages (CD163) were assessed by immunofluorescence on paraffin-embedded samples from

resultswe observed a predominantly intraepithelial CD3+ distribution in OE but both an intraepithelial and stromal pattern in EAOC (

conclusionsthe dysregulation of TILs, TAMs, and T-cell exhaustion might play a role in the malignization of OE to EAOC.

Indexed as

EndometriosisOvarian NeoplasmsCD3 ComplexFemaleForkhead Transcription FactorsHepatitis A Virus Cellular Receptor 2HumansLymphocytes, Tumor-InfiltratingProgrammed Cell Death 1 ReceptorCD3 ComplexForkhead Transcription FactorsHepatitis A Virus Cellular Receptor 2Programmed Cell Death 1 ReceptorCD163 macrophagesCD39endometriosisendometriosis-associated ovarian cancerFOXP3PD-1TIM3tumour-infiltrating lymphocytes

Identifiers

PMID37569458
PMCPMC10418839
OpenAlexW4385342990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.